SCHEMBL24953188

SCHEMBL24953188

CC(=O)c1ccc(F)c(OCCCc2c(C)n[nH]c2C)c1

nearest known ligand 0.83

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 6/20 0.83
▸ ALB P02768 1/20 0.83
▸ SMN1; SMN2 Q16637 7/20 0.51
▸ HSD17B10 Q99714 6/20 0.51
▸ MAPT P10636 4/20 0.51
▸ GAA P10253 1/20 0.51
▸ LMNA P02545 4/20 0.48
▸ HTT P42858 3/20 0.48
▸ TSHR P16473 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ MAPK1 P28482 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17522783 0.97 TTR (0.81) TTRALBSMN1; SMN2HSD17B10MAPT
Acoramidis SCHEMBL29350324 0.91 TTR (1.00) TTRALBSMN1; SMN2HSD17B10MAPT
Acoramidis SCHEMBL15816954 0.91 TTR (1.00) TTRALBSMN1; SMN2HSD17B10MAPT
SCHEMBL17522792 0.91 TTR (0.69) TTRALBSMN1; SMN2HSD17B10MAPT
SCHEMBL15816998 0.90 TTR (0.81) TTRALBSMN1; SMN2HSD17B10MAPT
Acoramidis SCHEMBL29390976 0.90 TTR (0.98) TTRALBSMN1; SMN2HSD17B10MAPT
Acoramidis SCHEMBL20475239 0.90 TTR (0.98) TTRALBSMN1; SMN2HSD17B10MAPT
SCHEMBL15816962 0.89 TTR (1.00) TTRALBSMN1; SMN2HSD17B10MAPT
SCHEMBL15832081 0.88 TTR (0.95) TTRALBSMN1; SMN2HSD17B10MAPT
SCHEMBL26740155 0.88 TTR (0.65) TTRALBSMN1; SMN2HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009612-A1 ACORAMIDIS (3-(3-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)PROPOXY)-4-FLUOROBENZOIC ACID) DERIVATIVES FOR STABILIZING TRANSTHYRETIN (TTS) AND INHIBITING TTS MISFOLDING FOR THE TREATMENT OF E.G. PERIPHERAL TTR AMYLOIDOSIS PROTEGO BIOPHARMA, INC. (US) 2023-02-02 — — WO disclosed
Send feedback